Aika Zhejiang Asset Management

Zhejiang Aika Asset Management (Aika) is a prominent Chinese financial and commercial group headquartered in Hangzhou, Zhejiang Province. Founded in 2014, the company operates across diverse sectors including automotive financing and the distribution of consumer goods, cosmetics, and health products. In 2025, Aika established a major strategic joint venture with the French laboratory Valbiotis to exclusively commercialize a portfolio of scientifically tested, plant-based dietary supplements across key Asian markets. Leveraging its robust infrastructure in cross-border e-commerce (CBEC) and traditional retail channels, Aika focuses on addressing metabolic and cardiovascular health needs in regions such as China, Japan, and Southeast Asia. The group is supported by significant institutional investors, including Sunshine Insurance Group and Gaorong Ventures.